Skip to content

TG Therapeutics

US · TGTX #1638 by market cap Listed 1970
63.34 -1.54 -2.37%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Quant vs Street three independent views, side by side

StockVane factor grade
A-
Momentum strategy signal
Hold
Analyst consensus
Buy

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

Analyst consensus 6 analysts

Buy
Avg price target 76.40 +20.6%
Price target rangecurrent 63.34
Low71.00
Avg76.40
High86.00
Buy 83% Hold 0% Sell 17%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-11-10 BofA Securities -- Sell --
2026-11-10 Evercore -- Buy 71.00
2026-11-09 TD Cowen -- Buy 75.00
2026-11-09 J.P. Morgan -- Buy 72.00
2026-10-25 J.P. Morgan -- Buy --
2026-09-21 H.C. Wainwright -- Buy 78.00
2026-09-02 B. Riley Securities -- Buy 86.00
2026-09-01 H.C. Wainwright -- Buy 78.00
2026-08-10 J.P. Morgan -- Buy 72.00
2026-08-05 BofA Securities -- Sell 21.00
2026-08-04 H.C. Wainwright -- Buy 78.00
2026-08-03 TD Cowen -- Buy 75.00
2026-08-03 H.C. Wainwright -- Buy 78.00
2026-07-20 TD Cowen -- Buy 75.00
2026-07-16 J.P. Morgan -- Buy 65.00
2026-07-14 Jefferies -- Buy 83.00
2026-07-13 H.C. Wainwright -- Buy 77.00
2026-07-07 BofA Securities -- Sell 20.00
2026-07-06 H.C. Wainwright -- Buy 70.00
2026-06-21 Jefferies -- Buy 83.00
2026-06-09 H.C. Wainwright -- Buy 70.00
2026-06-04 BofA Securities -- Sell 17.00
2026-06-04 H.C. Wainwright -- Buy 70.00
2026-06-03 Goldman Sachs -- Hold 41.00
2026-06-03 H.C. Wainwright -- Buy 70.00

Price target trend monthly average, last 3 years

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q3 2026-11-09 -- ±10.18% +5.94% (in line)
2026/Q2 2026-08-03 -- ±11.70% -11.26% (in line)
2026/Q1 2026-05-06 -- ±8.84% +16.26% (beat)
2025/Q4 2026-02-26 -- ±10.46% +4.18% (in line)
2025/Q3 2025-11-03 -- ±14.48% -3.13% (in line)
2025/Q2 2025-08-04 -- ±14.55% -17.99% (beat)
2025/Q1 2025-05-05 -- ±13.78% -13.26% (in line)
2024/Q4 2025-03-03 -- ±13.16% +14.39% (beat)
2024/Q3 2024-11-04 -- ±17.85% -9.44% (in line)
2024/Q2 2024-08-06 -- ±23.03% +19.58% (in line)
2024/Q1 2024-05-01 -- ±8.76% +16.25% (beat)
2023/Q4 2024-02-28 -- ±17.58% +26.74% (beat)

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-11-20 20:02:20 · For reference only, not investment advice and not tailored to your situation.

TG Therapeutics discussion 0 comments

Add a comment